TSX · BLCO.TO
Bausch + Lomb Corporation
CA$28.10-CA$0.65 (-2.26%)
Bausch + Lomb Corporation’s quoted price sits in the upper half of its reported 52-week range, 5.48% below the high.
Loading market information…
CNQ · BCBC.CN · CAD
Stock price, earnings
Quote as of Mar 21, 2025, 07:59 PM UTC. Cached market data; not a live quote.
One-year closing-price history · CAD. Historical prices are not a forecast.
The BC Bud Corporation’s quoted price sits in the lower half of its reported 52-week range, 74.19% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow The BC Bud Corporation’s reporting calendar.
THE COMPANY BEHIND THE TICKER
The BC Bud Corporation is a Canadian enterprise focused on the adult-use cannabis market, specializing in the production, licensing, and distribution of cannabis goods. Its diverse product portfolio caters to various consumer preferences, including traditional dried cannabis flower. The company also offers a variety of edible formulations, such as its distinctive "Canna Beans" brand, which features chocolate-covered coffee beans infused with cannabis, alongside high-potency concentrates marketed under the "Solventless Solutions" label. Furthermore, they provide novel cannabis-infused beverages, specifically their "Buds" brand, designed to emulate the experience of drinking beer. Additionally, the company extends its brand presence through lifestyle apparel. The company maintains its headquarters in Vancouver, Canada.
Latest available per-share figures in CAD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:18 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CA$28.10-CA$0.65 (-2.26%)
Bausch + Lomb Corporation’s quoted price sits in the upper half of its reported 52-week range, 5.48% below the high.
CA$33.44-CA$0.24 (-0.7%)
Apotex Health Corp.’s quoted price sits in the upper half of its reported 52-week range, 16.79% below the high.
CA$0.04+CA$0.01 (+16.67%)
Willow Biosciences Inc.’s quoted price sits in the lower half of its reported 52-week range, 95.17% below the high.
CA$0.01CA$0.00 (0.0%)
Heritage Cannabis Holdings Corp.’s quoted price sits in the lower half of its reported 52-week range, 75.0% below the high.
$5.85$0.00 (+0.23%)
Clearmind Medicine Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.78% below the high.
CA$0.01+CA$0.01 (+100.0%)
Luff Enterprises Ltd.: Healthcare · Drug Manufacturers - Specialty & Generic.
CA$0.01-CA$0.01 (-33.33%)
Filament Health Corp.’s quoted price sits in the lower half of its reported 52-week range, 85.71% below the high.
$0.00$0.00 (0.0%)
StageZero Life Sciences Ltd.’s quoted price sits in the lower half of its reported 52-week range, 91.45% below the high.
